An analysis of PMTA applications: what they reveal about the US market

In May 2021, the US Food and Drug Administration (FDA) published the long-awaited list of deemed new tobacco products which are the subject of premarket tobacco product applications (PMTAs). This list will be regularly updated by the FDA as it updates its “positive or negative” actions on the products which have been submitted.

ECigIntelligence has carried out some analysis of this list in order to understand how the US market may change in a post-PMTA regulated market.

The list contains over 6m products submitted by 372 companies. Of those products, 99.9% are stand-alone e-liquid products and of those, 80% of the submissions were from a single company.

It appears some applicants have developed an automated method to submit products to the FDA portal, which has allowed multiple e-liquid formats and flavours, with minor differences (for example, in size, nicotine strength etc) to be submitted separately. As such, analysis of the e-liquid products does not provide much insight into the future of the e-liquid market in the US, as it would seem unlikely that a large proportion of these submissions will achieve marketing approval.

In this analysis, we look at all the PMTA-submitted products which are not bottled e-liquid products (consisting of hardware, hardware components, or other nicotine- containing products).

...
Free Sample

Table of contents

  1. Executive summary
  2. Introduction
  3. Disposables and pre-filled pods
  4. Flavours
  5. Open system hardware
  6. Other nicotine-containing products

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Get a free sample of this report:

“ An analysis of PMTA applications: what they reveal about the US market ”





    Buy report request information:

    “ An analysis of PMTA applications: what they reveal about the US market ”





      Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.

      FREE TRIAL